Has Sharmini Jayamaha, MD received payments from drug or device companies?

Yes. Drug and device makers reported $286 in general payments to Sharmini Jayamaha, MD across 5 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sharmini Jayamaha, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sharmini Jayamaha, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sharmini Jayamaha, MD

Nephrology · Riverhead, NYNPI 1912942558

Payments from drug & device makers

$286in general payments, 2019–2025

Across 5 payments — averaging $57.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bayer$138
Akebia Therapeutics Inc$120
Travere Therapeutics, Inc.$28

What the payments were for

Food & beverage$286100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bayer	2	$138
Akebia Therapeutics Inc	2	$120
Travere Therapeutics, Inc.	1	$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Kerendia$123
Vafseo$103

How this compares

$286 in reported general payments places this provider in the 30th percentile of 935 nephrology providers in New York.

See all nephrology providers in New York →

Medicare billing

Part B allowed, 2024

$296,314

Medicare patients

473

Services billed

1,671

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	65	$96,154
VelphoroSucroferric Oxyhydroxide	11	$73,710
FarxigaDapagliflozin Propanediol	26	$40,294
LokelmaSodium Zirconium Cyclosilicate	26	$20,885
VeltassaPatiromer Calcium Sorbitex	13	$16,694
Calcium Acetate	59	$7,164
Sevelamer Carbonate	19	$5,563
Chlorthalidone	52	$1,813
Calcitonin-SalmonCalcitonin,salmon,synthetic	12	$1,773
Potassium Citrate ErPotassium Citrate	26	$1,529
Losartan Potassium	129	$1,443
Nateglinide	20	$1,387
Hydralazine Hcl	78	$1,243
Amlodipine Besylate	160	$1,003
Torsemide	47	$870

Paid to pharmacies, not to this prescriber.

Other nephrology in Riverhead

Joji TokitaNew York$8.4M
Krzysztof KirylukNew York$6.7M
David BernardNew York$6M
Andrew BombackNew York$3.4M
Pietro CanettaNew York$3.2M
Robert LynnBronx$2M
Jodumutt BhatMaspeth$1.5M
Gerald AppelNew York$1.5M
David CharytanNew York$1.3M
Frank CortazarAlbany$1.1M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →